Cargando…
Combination of anti‐CD4 antibody treatment and donor lymphocyte infusion ameliorates graft‐versus‐host disease while preserving graft‐versus‐tumor effects in murine allogeneic hematopoietic stem cell transplantation
Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is not only a well‐established immunotherapy for hematologic malignancies, but is potentially useful for treating solid tumors refractory to available therapies. However, application of allo‐HSCT to solid tumors is limited, despite the b...
Autores principales: | Ueha, Satoshi, Yokochi, Shoji, Ishiwata, Yoshiro, Kosugi‐Kanaya, Mizuha, Shono, Yusuke, Shibayama, Shiro, Ito, Satoru, Matsushima, Kouji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623734/ https://www.ncbi.nlm.nih.gov/pubmed/28787768 http://dx.doi.org/10.1111/cas.13346 |
Ejemplares similares
-
Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice
por: Kosugi-Kanaya, Mizuha, et al.
Publicado: (2017) -
Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice
por: Chen, Chang-Yu, et al.
Publicado: (2019) -
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023) -
High‐density lipoprotein infusion protects from acute graft‐versus‐host disease in experimental allogeneic hematopoietic cell transplantation
por: Chagué, Cécile, et al.
Publicado: (2022) -
Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)